73 related articles for article (PubMed ID: 7909149)
1. Tranquillising actions.
Pollard A; Friedman T; Aslam M
Nurs Times; 1994 Mar 16-22; 90(11):34-6. PubMed ID: 7909149
[No Abstract] [Full Text] [Related]
2. Drugs for psychotic disorders.
Treat Guidel Med Lett; 2010 Aug; 8(96):61-4; quiz two pages following last numbered page.. PubMed ID: 20651640
[No Abstract] [Full Text] [Related]
3. Metabolic disturbances associated with antipsychotic use.
Newcomer JW
J Clin Psychiatry; 2001; 62 Suppl 27():3-4; discussion 40-1. PubMed ID: 11806487
[No Abstract] [Full Text] [Related]
4. [Drug treatment of functional psychotic disorders].
Bridler R; Umbricht D; Hell D
Praxis (Bern 1994); 2001 May; 90(22):981-6. PubMed ID: 11450186
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
Buckley PF
CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
[No Abstract] [Full Text] [Related]
6. Neuroprotection: a new strategy in the treatment of schizophrenia. Early detection and intervention.
Perkins DO
CNS Spectr; 2007 Oct; 12(10 Suppl 18):10-3. PubMed ID: 19322959
[No Abstract] [Full Text] [Related]
7. Antipsychotic polypharmacy: do benefits justify the risks?
Tapp AM; Wood AE; Kilzieh N; Kennedy A; Raskind MA
Ann Pharmacother; 2005 Oct; 39(10):1759-60. PubMed ID: 16144885
[No Abstract] [Full Text] [Related]
8. The art of rational neuroleptic therapy.
Ayd FJ
Isr J Psychiatry Relat Sci; 1983; 20(4):292-8. PubMed ID: 6147324
[No Abstract] [Full Text] [Related]
9. The CATIE study and its implications for antipsychotic drug use.
Janicak PG
Essent Psychopharmacol; 2006; 7(1):53-63. PubMed ID: 16989293
[No Abstract] [Full Text] [Related]
10. [Diagnostic principles for differential therapy of psychoses].
Hell D; Bridler R
Praxis (Bern 1994); 2001 May; 90(22):975-80. PubMed ID: 11450185
[TBL] [Abstract][Full Text] [Related]
11. Legal fallacies of antipsychotic drugs.
Erickson SK; Ciccone JR; Schwarzkopf SB; Lamberti JS; Vitacco MJ
J Am Acad Psychiatry Law; 2007; 35(2):235-46. PubMed ID: 17592170
[TBL] [Abstract][Full Text] [Related]
12. Focus on ziprasidone.
Green B
Curr Med Res Opin; 2001; 17(2):146-50. PubMed ID: 11759185
[TBL] [Abstract][Full Text] [Related]
13. Introduction. Weight gain with psychotropics: size does matter.
Masand PS
J Clin Psychiatry; 1999; 60 Suppl 21():3-4. PubMed ID: 10548134
[No Abstract] [Full Text] [Related]
14. Clozapine.
Nurs Times; 2005 Nov 1-7; 101(44):31. PubMed ID: 16295587
[No Abstract] [Full Text] [Related]
15. [Therapeutic effects of butyrilperazine].
Bohacek N
Neuropsihijatrija; 1964; 12(1-4):133-6. PubMed ID: 16305166
[No Abstract] [Full Text] [Related]
16. Benefits of atypical antipsychotic medications in the treatment of psychosis.
White DL
Kans Nurse; 2003; 78(10):1-2. PubMed ID: 14746070
[No Abstract] [Full Text] [Related]
17. Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
Montejo AL; Rico-Villademoros F;
J Clin Psychopharmacol; 2008 Oct; 28(5):568-70. PubMed ID: 18794656
[No Abstract] [Full Text] [Related]
18. Clinical experience with insulin resistance, diabetic ketoacidosis, and type 2 diabetes mellitus in patients treated with atypical antipsychotic agents.
Henderson DC
J Clin Psychiatry; 2001; 62 Suppl 27():10-4; discussion 40-1. PubMed ID: 11806484
[TBL] [Abstract][Full Text] [Related]
19. [Paliperidone].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 2006 Aug; 29(8):280-2. PubMed ID: 16927595
[No Abstract] [Full Text] [Related]
20. [Second generation antipsychotics: similarities and differences].
Jarema M; Rybakowski J; Landowski J
Psychiatr Pol; 2003; 37(1):7-28. PubMed ID: 12685300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
